Idioma:

A Novel Nanoprobe for Multimodal Imaging Is Effectively Incorporated into Human Melanoma Metastatic Cell Lines

Aasen, Synnøve Nymark ; Pospisilova, Aneta ; Eichler, Tilo Wolf ; Panek, Jiri ; Hruby, Martin ; Stepanek, Petr ; Spriet, Endy ; Jirak, Daniel ; Skaftnesmo, Kai Ove ; Thorsen, Frits

International journal of molecular sciences, 2015-09, Vol.16 (9), p.21658-21680 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por

Enviar para

Título:
A Novel Nanoprobe for Multimodal Imaging Is Effectively Incorporated into Human Melanoma Metastatic Cell Lines
Autor: Aasen, Synnøve Nymark ; Pospisilova, Aneta ; Eichler, Tilo Wolf ; Panek, Jiri ; Hruby, Martin ; Stepanek, Petr ; Spriet, Endy ; Jirak, Daniel ; Skaftnesmo, Kai Ove ; Thorsen, Frits
Assuntos: Brain ; Cell Line, Tumor ; Cell Movement ; Cell Survival ; Contrast Media - chemistry ; Cytoplasm - metabolism ; fluorescence lifetime correlation spectroscopy ; fluorescence microscopy ; Glycogen - metabolism ; high throughput microscopy ; Humans ; Hydrogen-Ion Concentration ; Lysosomes - metabolism ; magnetic resonance imaging ; Magnetic Resonance Imaging - methods ; Melanoma ; Melanoma - metabolism ; Melanoma - pathology ; melanoma brain metastasis ; Metastasis ; Microscopy ; Molecular Imaging - methods ; Molecular Probes ; Multimodal Imaging ; nanoprobe ; Nanotechnology ; NMR ; Nuclear magnetic resonance ; Spectrometry, Fluorescence ; Staining and Labeling ; theranostics ; zeta potential
É parte de: International journal of molecular sciences, 2015-09, Vol.16 (9), p.21658-21680
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: To facilitate efficient drug delivery to tumor tissue, several nanomaterials have been designed, with combined diagnostic and therapeutic properties. In this work, we carried out fundamental in vitro and in vivo experiments to assess the labeling efficacy of our novel theranostic nanoprobe, consisting of glycogen conjugated with a red fluorescent probe and gadolinium. Microscopy and resazurin viability assays were used to study cell labeling and cell viability in human metastatic melanoma cell lines. Fluorescence lifetime correlation spectroscopy (FLCS) was done to investigate nanoprobe stability. Magnetic resonance imaging (MRI) was performed to study T₁ relaxivity in vitro, and contrast enhancement in a subcutaneous in vivo tumor model. Efficient cell labeling was demonstrated, while cell viability, cell migration, and cell growth was not affected. FLCS showed that the nanoprobe did not degrade in blood plasma. MRI demonstrated that down to 750 cells/μL of labeled cells in agar phantoms could be detected. In vivo MRI showed that contrast enhancement in tumors was comparable between Omniscan contrast agent and the nanoprobe. In conclusion, we demonstrate for the first time that a non-toxic glycogen-based nanoprobe may effectively visualize tumor cells and tissue, and, in future experiments, we will investigate its therapeutic potential by conjugating therapeutic compounds to the nanoprobe.
Editor: Switzerland: MDPI AG
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

A Novel Nanoprobe for Multimodal Imaging Is Effectively Incorporated into Human Melanoma Metastatic Cell Lines

Aasen, Synnøve Nymark ; Pospisilova, Aneta ; Eichler, Tilo Wolf ; Panek, Jiri ; Hruby, Martin ; Stepanek, Petr ; Spriet, Endy ; Jirak, Daniel ; Skaftnesmo, Kai Ove ; Thorsen, Frits

Switzerland: MDPI AG

Buscando em bases de dados remotas. Favor aguardar.